Pharmaceuticals · Key players

Top Duchenne Muscular Dystrophy Treatment companies

The 5 key players our Duchenne Muscular Dystrophy Treatment report profiles, and other companies free public records show in this market.

Key players in Duchenne Muscular Dystrophy Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Duchenne Muscular Dystrophy Treatment market
#CompanyWebsiteOur reports
1 Sarepta Therapeutics — 66 reports
2 PTC Therapeutics — 99 reports
3 Italfarmaco — 33 reports
4 Santhera Pharmaceuticals — 33 reports
5 NS Pharma — 33 reports

Also active in Duchenne Muscular Dystrophy Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Duchenne Muscular Dystrophy Treatment, from free public records
CompanyWhere public records show them
Sarepta Theraps Inc
Zydus Lifesciences
Upsher Smith Laboratories
Entrada Therapeutics, Inc.
Solid Biosciences Inc.
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Roche
Amneal Pharmaceuticals, Inc
Avidity Biosciences, Inc.
REGENXBIO
Tris Pharma Inc

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Duchenne Muscular Dystrophy Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. NS Pharma 4 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Sarepta Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Italfarmaco 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Entrada Therapeutics, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Solid Biosciences Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Roche 2 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Avidity Biosciences, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. REGENXBIO 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Duchenne Muscular Dystrophy Treatment reports by place

One report for each place. Each tile opens that place's report.

Regions 7

World report Africa report APAC report Europe report Latin America report Middle East report North America report

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Duchenne Muscular Dystrophy Treatment, with active trials

Get the full Duchenne Muscular Dystrophy Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.